NPS Pharmaceuticals Cash from Investing Quarterly:
-17.40M for Dec. 31, 2012NPS Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -17.40M |
| Sept. 30, 2012 | 12.41M |
| June 30, 2012 | 8.382M |
| March 31, 2012 | -9.881M |
| Dec. 31, 2011 | -42.32M |
| Sept. 30, 2011 | 23.99M |
| June 30, 2011 | 0.306M |
| March 31, 2011 | -10.10M |
| Dec. 31, 2010 | 4.40M |
| Sept. 30, 2010 | 1.788M |
| June 30, 2010 | -26.61M |
| March 31, 2010 | 19.69M |
| Dec. 31, 2009 | 15.77M |
| Sept. 30, 2009 | 0.747M |
| June 30, 2009 | -17.29M |
| March 31, 2009 | 6.013M |
| Dec. 31, 2008 | -36.43M |
| Sept. 30, 2008 | -0.062M |
| June 30, 2008 | 1.647M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
NPSP Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| ACADIA Pharmaceuticals | -35.05M |
| Vertex Pharmaceuticals | |
| United Therapeutics Corporation | 10.64M |
NPSP Cash from Investing Quarterly Rankings
| Overall |
62nd percentile 3034 of 8002 |
| Sector |
35th percentile 442 of 684 in Healthcare |
| Industry |
28th percentile 178 of 248 in Biotechnology |
NPSP Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -42.32M | Dec 2011 |
| Maximum | 23.99M | Sep 2011 |
| Average | -3.418M |
